{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:11Z","timestamp":1761864311564},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T00:00:00Z","timestamp":1625616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>C-erbB-2 has been confirmed to be an oncogene that participates in cell growth, differentiation and division of tumors. We are wondered if its silenced expression can exert an anti-tumor effect. Therefore, this study is conducted to investigate the mechanism of C-erbB-2 silencing and IGF-1 pathway on esophageal carcinoma (EC) cell biological behaviors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The objects of study were 84 EC patients from Heping Hospital Affiliated to Changzhi Medical College, with the collection of EC tissue and adjacent normal tissue (&gt;\u20095\u2009cm away from cancer tissue). C-erbB-2 protein expression in EC tissues was detected by immunohistochemistry. Human EC cell line Eca-109 was purchased from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Based on different transfection protocols, EC cells with logarithmic growth phase of 3\u20135 passages were divided into blank control group, oe-C-erbB-2 NC group, siRNA C-erbB-2 NC group, oe-C-erbB-2 group, siRNA C-erbB-2 group, OSI-906 group, Rg5 group, Rg5\u2009+\u2009siRNA C-erbB-2 NC group and Rg5\u2009+\u2009siRNA C-erbB-2 group. Cell proliferation was detected by MTT assay; cell cycle distribution and apoptosis by flow cytometry; C-erbB-2, IGF-1, IGF-1R and Akt mRNA and protein expressions by qRT-PCR and western blot; and cell invasion and migration by Transwell assay and scratch test. Tumor growth was observed in male BALB\/c nude mice (Shanghai Experimental Animal Center) based on Eca109 cell implantation, raising, and measurement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>C-erbB-2, IGF-1, IGF-1R and Akt expression were higher in EC tissues than those in adjacent tissues (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Compared with blank control group, both si-C-erbB-2 and OSI-906 groups had decreased IGF-1, IGF-1R and Akt mRNA and protein expressions, decreased cell proliferation, migration and invasion, prolonged G0\/G1 phase, shortened S phase, increased cell apoptosis, and inhibited tumor growth (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05); while opposite trends were detected in C-erbB-2 vector and Rg5 groups (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), without statistical differences in siRNA C-erbB-2\u2009+\u2009Rg5 group (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Silencing C-erbB-2 expression may inhibit EC cell proliferation, promote cell apoptosis and block cell cycle progression by inhibiting IGF-1 pathway activation. The beneficial effect of silencing C-erbB-2 expression can be reversed by promoting the activation of IGF-1 pathway. Findings in our study may provide potential reference for understanding the molecular mechanism of EC and supply possible axis for preventing the development of EC from the perspective of molecular biology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-021-01540-9","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T19:13:26Z","timestamp":1625685206000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation"],"prefix":"10.1186","volume":"16","author":[{"given":"Zhigao","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"issue":"1","key":"1540_CR1","doi-asserted-by":"publisher","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","volume":"3","author":"EC Smyth","year":"2017","unstructured":"Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, et al. Oesophageal cancer. Nat Rev Dis Primers. 2017;3(1):17048. https:\/\/doi.org\/10.1038\/nrdp.2017.48.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"1540_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox072","volume":"30","author":"F Tustumi","year":"2017","unstructured":"Tustumi F, Bernardo WM, da Rocha JRM, Szachnowicz S, Seguro FC, Bianchi ET, et al. Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis. Dis Esophagus. 2017;30(10):1\u20138. https:\/\/doi.org\/10.1093\/dote\/dox072.","journal-title":"Dis Esophagus"},{"issue":"1","key":"1540_CR3","first-page":"22","volume":"95","author":"MW Short","year":"2017","unstructured":"Short MW, Burgers KG, Fry VT. Esophageal Cancer. Am Fam Physician. 2017;95(1):22\u20138.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1540_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.gie.2018.04.2352","volume":"88","author":"DC Codipilly","year":"2018","unstructured":"Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88(3):413\u201326. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2352.","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"1540_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.13955","volume":"1434","author":"S Monig","year":"2018","unstructured":"Monig S, et al. Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation. Ann N Y Acad Sci. 2018;1434(1):115\u201323. https:\/\/doi.org\/10.1111\/nyas.13955.","journal-title":"Ann N Y Acad Sci"},{"issue":"26","key":"1540_CR6","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","volume":"21","author":"MJ Domper Arnal","year":"2015","unstructured":"Domper Arnal MJ, arenas AF, Arbeloa AL. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933\u201343. https:\/\/doi.org\/10.3748\/wjg.v21.i26.7933.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1540_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gie.2018.07.037","volume":"89","author":"Y Horie","year":"2019","unstructured":"Horie Y, Yoshio T, Aoyama K, Yoshimizu S, Horiuchi Y, Ishiyama A, et al. Diagnostic outcomes of esophageal cancer by artificial intelligence using convolutional neural networks. Gastrointest Endosc. 2019;89(1):25\u201332. https:\/\/doi.org\/10.1016\/j.gie.2018.07.037.","journal-title":"Gastrointest Endosc"},{"key":"1540_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.arr.2017.12.002","volume":"42","author":"J Frater","year":"2018","unstructured":"Frater J, Lie D, Bartlett P, McGrath JJ. Insulin-like growth factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: a review. Ageing Res Rev. 2018;42:14\u201327. https:\/\/doi.org\/10.1016\/j.arr.2017.12.002.","journal-title":"Ageing Res Rev"},{"issue":"5 Pt B","key":"1540_CR9","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.bbadis.2017.08.029","volume":"1864","author":"WS Lee","year":"2018","unstructured":"Lee WS, Kim J. Insulin-like growth factor-1 signaling in cardiac aging. Biochim Biophys Acta Mol basis Dis. 2018;1864(5 Pt B):1931\u20138.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"1540_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ecoenv.2019.06.017","volume":"181","author":"P Shao","year":"2019","unstructured":"Shao P, Wang Y, Zhang M, Wen X, Zhang J, Xu Z, et al. The interference of DEHP in precocious puberty of females mediated by the hypothalamic IGF-1\/PI3K\/Akt\/mTOR signaling pathway. Ecotoxicol Environ Saf. 2019;181:362\u20139. https:\/\/doi.org\/10.1016\/j.ecoenv.2019.06.017.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"1540_CR11","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1159\/000479207","volume":"42","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Li S, Li J, Wang D, Li Q. Effect of microRNA-135a on cell proliferation, migration, invasion, apoptosis and tumor angiogenesis through the IGF-1\/PI3K\/Akt signaling pathway in non-small cell lung Cancer. Cell Physiol Biochem. 2017;42(4):1431\u201346. https:\/\/doi.org\/10.1159\/000479207.","journal-title":"Cell Physiol Biochem"},{"issue":"21","key":"1540_CR12","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1038\/s41388-019-0694-9","volume":"38","author":"A Choucair","year":"2019","unstructured":"Choucair A, Pham TH, Omarjee S, Jacquemetton J, Kassem L, Tr\u00e9dan O, et al. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer. Oncogene. 2019;38(21):4015\u201327. https:\/\/doi.org\/10.1038\/s41388-019-0694-9.","journal-title":"Oncogene"},{"issue":"25","key":"1540_CR13","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1038\/s41388-018-0222-3","volume":"37","author":"PC Chu","year":"2018","unstructured":"Chu PC, Lin PC, Wu HY, Lin KT, Wu C, Bekaii-Saab T, et al. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Oncogene. 2018;37(25):3440\u201355. https:\/\/doi.org\/10.1038\/s41388-018-0222-3.","journal-title":"Oncogene"},{"key":"1540_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejphar.2017.08.025","volume":"814","author":"G Wang","year":"2017","unstructured":"Wang G, Lu M, Yao Y, Wang J, Li J. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1\/PI3K\/Akt signaling pathway. Eur J Pharmacol. 2017;814:207\u201315. https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.025.","journal-title":"Eur J Pharmacol"},{"key":"1540_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","volume":"834","author":"YT Lee","year":"2018","unstructured":"Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188\u201396. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.034.","journal-title":"Eur J Pharmacol"},{"issue":"144","key":"1540_CR16","first-page":"219","volume":"26","author":"LY Guan","year":"2018","unstructured":"Guan LY, Lu Y. New developments in molecular targeted therapy of ovarian cancer. Discov Med. 2018;26(144):219\u201329.","journal-title":"Discov Med"},{"issue":"2","key":"1540_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3892\/ijo.2017.4214","volume":"52","author":"B Rong","year":"2018","unstructured":"Rong B, Yang S. Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: new discoveries and developments (review). Int J Oncol. 2018;52(2):321\u201336. https:\/\/doi.org\/10.3892\/ijo.2017.4214.","journal-title":"Int J Oncol"},{"issue":"5","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3904\/kjim.2017.008","volume":"32","author":"JY Kim","year":"2017","unstructured":"Kim JY, Cho CH, Song HS. Targeted therapy of ovarian cancer including immune check point inhibitor. Korean J Intern Med. 2017;32(5):798\u2013804. https:\/\/doi.org\/10.3904\/kjim.2017.008.","journal-title":"Korean J Intern Med"},{"key":"1540_CR19","first-page":"CD011461","volume":"7","author":"H Song","year":"2016","unstructured":"Song H, Zhu J, Lu D. Molecular-targeted first-line therapy for advanced gastric cancer. Cochrane Database Syst Rev. 2016;7:CD011461.","journal-title":"Cochrane Database Syst Rev"},{"key":"1540_CR20","unstructured":"Smith CIE, Blomberg P. Gene therapy - from idea to reality. Lakartidningen. 2017:114. https:\/\/lakartidningen.se\/klinik-och-vetenskap-1\/artiklar-1\/klinisk-oversikt\/2017\/12\/genterapi-fran-ide-till-verklighet\/."},{"key":"1540_CR21","doi-asserted-by":"publisher","unstructured":"Ono C, et al. Baculovirus as a Tool for Gene Delivery and Gene Therapy. Viruses. 2018;10(9):510\u201312. https:\/\/doi.org\/10.3390\/v10090510.","DOI":"10.3390\/v10090510"},{"issue":"1\u20132","key":"1540_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1615\/CritRevOncog.2016016084","volume":"21","author":"H Lara-Guerra","year":"2016","unstructured":"Lara-Guerra H, Roth JA. Gene therapy for lung Cancer. Crit Rev Oncog. 2016;21(1\u20132):115\u201324. https:\/\/doi.org\/10.1615\/CritRevOncog.2016016084.","journal-title":"Crit Rev Oncog"},{"issue":"146","key":"1540_CR23","first-page":"45","volume":"27","author":"W Sun","year":"2019","unstructured":"Sun W, Shi Q, Zhang H, Yang K, Ke Y, Wang Y, et al. Advances in the techniques and methodologies of cancer gene therapy. Discov Med. 2019;27(146):45\u201355.","journal-title":"Discov Med"},{"issue":"2","key":"1540_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1517\/14712598.2016.1114096","volume":"16","author":"CJ Choong","year":"2016","unstructured":"Choong CJ, Baba K, Mochizuki H. Gene therapy for neurological disorders. Expert Opin Biol Ther. 2016;16(2):143\u201359. https:\/\/doi.org\/10.1517\/14712598.2016.1114096.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"1540_CR25","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1590\/s1679-45082017rb4024","volume":"15","author":"GAR Goncalves","year":"2017","unstructured":"Goncalves GAR, Paiva RMA. Gene therapy: advances, challenges and perspectives. Einstein (Sao Paulo). 2017;15(3):369\u201375. https:\/\/doi.org\/10.1590\/s1679-45082017rb4024.","journal-title":"Einstein (Sao Paulo)"},{"key":"1540_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/978-1-4939-7471-9_16","volume":"1706","author":"H Han","year":"2018","unstructured":"Han H. RNA interference to Knock down gene expression. Methods Mol Biol. 2018;1706:293\u2013302. https:\/\/doi.org\/10.1007\/978-1-4939-7471-9_16.","journal-title":"Methods Mol Biol"},{"issue":"6","key":"1540_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/ps.4813","volume":"74","author":"M Zotti","year":"2018","unstructured":"Zotti M, dos Santos EA, Cagliari D, Christiaens O, Taning CNT, Smagghe G. RNA interference technology in crop protection against arthropod pests, pathogens and nematodes. Pest Manag Sci. 2018;74(6):1239\u201350. https:\/\/doi.org\/10.1002\/ps.4813.","journal-title":"Pest Manag Sci"},{"key":"1540_CR28","doi-asserted-by":"publisher","unstructured":"Liu WR, Cao LR, Zuo GJ. Influence of chitosan nanoparticle-mediated C-erbB-2 gene silencing on invasion and apoptosis of Hep-2 cells. Genet Mol Res. 2016;15(4):gmr15048860. https:\/\/doi.org\/10.4238\/gmr15048860.","DOI":"10.4238\/gmr15048860"},{"issue":"2","key":"1540_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/ol.2018.8777","volume":"16","author":"M Nie","year":"2018","unstructured":"Nie M, Qin Y, Zhu J, Li Y, Wang Z. Correlation between ultrasonic features and expression levels of C-erbB-2, VEGF and nm23 in breast cancer. Oncol Lett. 2018;16(2):1701\u20137. https:\/\/doi.org\/10.3892\/ol.2018.8777.","journal-title":"Oncol Lett"},{"key":"1540_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopha.2018.02.045","volume":"101","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li Y, Li H, Chen W, Liu W. Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model. Biomed Pharmacother. 2018;101:391\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.045.","journal-title":"Biomed Pharmacother"},{"key":"1540_CR31","doi-asserted-by":"publisher","unstructured":"Saydam M, Yilmaz I. Effect of postoperative ischemia on steroid hormone receptors and c-erbB-2 levels in breast cancer tissue. Turk J Surg. 2018:1\u20135. Epub ahead of print. https:\/\/doi.org\/10.5152\/turkjsurg.2018.4001.","DOI":"10.5152\/turkjsurg.2018.4001"},{"issue":"3","key":"1540_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.prp.2018.12.015","volume":"215","author":"N Missaoui","year":"2019","unstructured":"Missaoui N, Landolsi H, Mestiri S, Essakly A, Abdessayed N, Hmissa S, et al. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21(WAF1\/Cip1), p63 and Ki-67 expression in hydatidiform moles. Pathol Res Pract. 2019;215(3):446\u201352. https:\/\/doi.org\/10.1016\/j.prp.2018.12.015.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"1540_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10388-018-0604-1","volume":"15","author":"Y Akutsu","year":"2018","unstructured":"Akutsu Y, Murakami K, Kano M, Toyozumi T, Matsumoto Y, Takahashi M, et al. The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma. Esophagus. 2018;15(2):103\u20138. https:\/\/doi.org\/10.1007\/s10388-018-0604-1.","journal-title":"Esophagus"},{"issue":"1","key":"1540_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12943-018-0936-4","volume":"18","author":"L Fan","year":"2019","unstructured":"Fan L, Cao Q, Liu J, Zhang J, Li B. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis. Mol Cancer. 2019;18(1):16. https:\/\/doi.org\/10.1186\/s12943-018-0936-4.","journal-title":"Mol Cancer"},{"issue":"8","key":"1540_CR35","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1245\/s10434-018-6554-y","volume":"25","author":"E Toxopeus","year":"2018","unstructured":"Toxopeus E, van der Schaaf M, van Lanschot J, Lagergren J, Lagergren P, van der Gaast A, et al. Outcome of patients treated within and outside a randomized clinical trial on Neoadjuvant Chemoradiotherapy plus surgery for esophageal Cancer: extrapolation of a randomized clinical trial (CROSS). Ann Surg Oncol. 2018;25(8):2441\u20138. https:\/\/doi.org\/10.1245\/s10434-018-6554-y.","journal-title":"Ann Surg Oncol"},{"key":"1540_CR36","first-page":"CD010511","volume":"8","author":"BA Vellayappan","year":"2017","unstructured":"Vellayappan BA, et al. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database Syst Rev. 2017;8:CD010511.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1540_CR37","doi-asserted-by":"publisher","first-page":"101042831769168","DOI":"10.1177\/1010428317691682","volume":"39","author":"M Zhao","year":"2017","unstructured":"Zhao M, Ang L, Huang J, Wang J. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis. Tumour Biol. 2017;39(2):1010428317691682. https:\/\/doi.org\/10.1177\/1010428317691682.","journal-title":"Tumour Biol"},{"issue":"1","key":"1540_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng K, He B, Yang BB, Xu T, Chen X, Xu M, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018;17(1):160. https:\/\/doi.org\/10.1186\/s12943-018-0914-x.","journal-title":"Mol Cancer"},{"issue":"1","key":"1540_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-017-0609-y","volume":"36","author":"PJ Zhou","year":"2017","unstructured":"Zhou PJ, Xue W, Peng J, Wang Y, Wei L, Yang Z, et al. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3\/aPKC\/KIBRA complex and inactivating the hippo pathway. J Exp Clin Cancer Res. 2017;36(1):139. https:\/\/doi.org\/10.1186\/s13046-017-0609-y.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"1540_CR40","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/ijc.30854","volume":"141","author":"S Laudato","year":"2017","unstructured":"Laudato S, Patil N, Abba ML, Leupold JH, Benner A, Gaiser T, et al. P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1. Int J Cancer. 2017;141(9):1879\u201390. https:\/\/doi.org\/10.1002\/ijc.30854.","journal-title":"Int J Cancer"},{"issue":"11","key":"1540_CR41","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41401-019-0287-8","volume":"40","author":"HH Zhong","year":"2019","unstructured":"Zhong HH, Wang HY, Li J, Huang YZ. TRAIL-based gene delivery and therapeutic strategies. Acta Pharmacol Sin. 2019;40(11):1373\u201385. https:\/\/doi.org\/10.1038\/s41401-019-0287-8.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"1540_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12943-017-0683-y","volume":"16","author":"Y Xin","year":"2017","unstructured":"Xin Y, Huang M, Guo WW, Huang Q, Zhang L, Jiang G. Nano-based delivery of RNAi in cancer therapy. Mol Cancer. 2017;16(1):134. https:\/\/doi.org\/10.1186\/s12943-017-0683-y.","journal-title":"Mol Cancer"},{"key":"1540_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","volume":"1060","author":"AE Denton","year":"2018","unstructured":"Denton AE, Roberts EW, Fearon DT. Stromal cells in the tumor microenvironment. Adv Exp Med Biol. 2018;1060:99\u2013114. https:\/\/doi.org\/10.1007\/978-3-319-78127-3_6.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"1540_CR44","doi-asserted-by":"publisher","first-page":"e0219713","DOI":"10.1371\/journal.pone.0219713","volume":"14","author":"L Benov","year":"2019","unstructured":"Benov L. Effect of growth media on the MTT colorimetric assay in bacteria. PLoS One. 2019;14(8):e0219713. https:\/\/doi.org\/10.1371\/journal.pone.0219713.","journal-title":"PLoS One"},{"issue":"9","key":"1540_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","volume":"10","author":"X Xia","year":"2019","unstructured":"Xia X, Wang X, Cheng Z, Qin W, Lei L, Jiang J, et al. The role of pyroptosis in cancer: pro-cancer or pro-\"host\"? Cell Death Dis. 2019;10(9):650. https:\/\/doi.org\/10.1038\/s41419-019-1883-8.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1540_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","volume":"18","author":"B Peltanova","year":"2019","unstructured":"Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18(1):63. https:\/\/doi.org\/10.1186\/s12943-019-0983-5.","journal-title":"Mol Cancer"},{"key":"1540_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4939-7845-8_4","volume":"1786","author":"AF van de Merbel","year":"2018","unstructured":"van de Merbel AF, et al. Protocols for migration and invasion studies in prostate Cancer. Methods Mol Biol. 2018;1786:67\u201379. https:\/\/doi.org\/10.1007\/978-1-4939-7845-8_4.","journal-title":"Methods Mol Biol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-021-01540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-021-01540-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-021-01540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T19:14:39Z","timestamp":1625685279000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-021-01540-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1186\/s13019-021-01540-9","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,7]]},"assertion":[{"value":"18 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this study, the specimen collection and clinical data collection were approved by the ethics committee of the hospital (approval No.: 2020\u2013045), and the informed consent of all patients and\/or their families was obtained before specimen collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}